Chipscreen Biosciences (688321.SH) released its performance for the first three quarters, with net profit attributable to the parent company of 91.17 million yuan, a year-on-year increase of 28.84%.

Zhitong Finance APP News, Chipscreen Biosciences (688321.SH) disclosed its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 841 million yuan, a year-on-year increase of 24.67%; net profit attributable to the parent company was 91.17 million yuan, a year-on-year increase of 28.84%; net profit after deducting non-recurring gains and losses was 79.09 million yuan, a year-on-year increase of 35.34%; basic earnings per share were 0.2093 yuan.